Attaché Report (GAIN)

South Africa: Fresh Deciduous Fruit Semi-annual

South Africa is set for a record pome fruit and table grape production in marketing year 2021/22. Favorable weather conditions, new areas under production, and higher yielding cultivars is driving the growth in production.
Attaché Report (GAIN)

Chile: Fresh Deciduous Fruit Semi-annual

In MY2021/22, Post projects that table grape production will increase by 15.2 percent, totaling 760,000 MT and exports will increase by 14.2 percent, totaling 600,000 metric tons. For MY2021/22, Post estimates apple production at 1,036,000 MT a 4.8 percent decrease from MY2020/21 on lower planted area.
India notified its draft Plant Quarantine (Regulation of Import into India) (Second Amendment) Order (2022), to the Sanitary-Phytosanitary (SPS) Committee of the World Trade Organization (WTO) and is inviting comments.
Attaché Report (GAIN)

New Zealand: Fresh Deciduous Fruit Semi-annual

New Zealand’s apple production and exports are forecast to rise in marketing year 2021/22
World Production, Markets, and Trade Report

Citrus: World Markets and Trade

This biannual report, published in January and July, includes data on U.S. and global trade, production, consumption and stocks, as well as analysis of developments affecting world trade in citrus.
Attaché Report (GAIN)

Guatemala: Agricultural Biotechnology Annual

Guatemala, at present, allows the importation of genetically engineered (GE) agricultural and food products, but has not approved the use of GE plants for agricultural production.
Attaché Report (GAIN)

Honduras: Agricultural Biotechnology Annual

Honduras is the only country in Central America that allows commercial production and field trials of agricultural biotech crops.
Attaché Report (GAIN)

China: Agricultural Biotechnology Annual

China is expected to remain a significant importer of biotech products and may become an exporter of biotechnology in the medium to long term.
Attaché Report (GAIN)

Costa Rica: Agricultural Biotechnology Annual

Recent high-profile activism against biotechnology has created uncertainty among those involved in production and research of biotechnology products in Costa Rica.